Spying synthetic lethal promise, Pfizer bets $25M on Zentalis, will support cancer trials

[cafead]

via Pfizer is throwing its weight behind Zentalis Pharmaceuticals’ synthetic lethality candidate, making a $25 million investment in its new partner and agreeing to jointly advance the prospect through the clinic.

article source